Pharma

Your Article Summary

See Latest Articles

Lumenis Invests in Exclusive, Worldwide License for New Ophthalmic Technology
Corporate News Releases - The Healthcare Sales & Marketing Network, 06/27/06

Lumenis Ltd., a global developer, manufacturer and seller of laser and light-based devices for medical, aesthetic, ophthalmic, dental and veterinary applications, announced that it has received exclusive worldwide licensing rights for SRT(TM), a new laser therapy for selectively treating retinal diseases. These rights include licenses issued to Lumenis by Medizinisches Laserzentrum Lubeck GmbH, Massachusetts General Hospital and Professor Reginald Birngruber

Today in Biotechnology...keeping you current

Receive free subspecialty "5-minute updates" via email

Safety First in Biotech Development
BioPharm, 12/03/09

Teva Announces The Submission Of A Biologics License Application (BLA) For XM02 For The Treatment Of Chemotherapy-Induced Neutropenia
Teva Pharmaceutical Industries, 12/02/09

Complete Genomics and GATC Biotech Collaborate on Human Genome Sequencing Projects
b3c newswire, 12/02/09

 See all of Biotechnology

Today in Marketing/Media/ROI...keeping you current

Receive free subspecialty "5-minute updates" via email

Prodesses ProParaflu+(TM) Assay Cleared for US Marketing by FDA
Gen-Probe, 12/03/09

Shire and Teva Settle Litigation Concerning Supply of ADDERALL XR Authorized Generic
Shire, 12/03/09

Chugai Revises Corporate Advertisement for First Time in Four Years
Chugai Pharmaceutical Co., 11/25/09

 See all of Marketing/Media/ROI